Paper Details

  1. Home
  2. Paper Details

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.

Author: BachmannGloria, BavendamTamara, GuanZhonghong, JumadilovaZhanna, MorrowJon D, RogersRebecca G, ScarperoHarriette, SunFranklin

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study found that tolterodine ER treatment was associated with improvements in multiple OAB- and incontinence-specific PROs in a sexually active, relatively young, and racially diverse population of women. 79% of women on tolterodine ER reported treatment benefit compared to 54% on placebo, and 78% reported treatment satisfaction compared to 59% on placebo.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the effects of tolterodine extended release (ER) on patient-reported outcomes (PROs) in sexually active women with overactive bladder (OAB) and urgency urinary incontinence (UUI). RESEARCH DESIGN AND METHODS: This multicenter, double-blind, placebo controlled trial included 411...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1185/03007990903103279

データ提供：米国国立医学図書館（NLM）

Tolterodine ER: Improving Quality of Life for Women with Overactive Bladder

Overactive bladder (OAB) is a common condition that significantly impacts a person's quality of life. This study investigates the effects of tolterodine extended release (ER) on patient-reported outcomes (PROs) in sexually active women with OAB and urgency urinary incontinence (UUI). The research involved a multicenter, double-blind, placebo-controlled trial with 411 women aged 18 years or older with OAB symptoms for at least 3 months. The authors found that tolterodine ER treatment led to significant improvements in various PROs, including bladder condition perception, OAB symptom bother, health-related quality of life, and treatment satisfaction.

A Beacon of Hope for Women with Overactive Bladder

The study's findings highlight the potential of tolterodine ER to significantly improve the quality of life for women with OAB. The observed improvements in PROs demonstrate its effectiveness in alleviating symptoms and enhancing overall well-being. This research underscores the importance of addressing OAB and its impact on women's lives through effective treatments and individualized care.

A Refreshing Oasis in the Desert of Urinary Incontinence

Imagine a desert where the only source of water is a distant oasis. This is the analogy for individuals with OAB, where the need for frequent urination and urinary incontinence can significantly impact their daily lives. This study offers hope for women with OAB, demonstrating the potential of tolterodine ER to improve their quality of life and bring them closer to a more comfortable and fulfilling existence.

Dr. Camel's Conclusion

This study is like a cool breeze in the desert of OAB symptoms, offering relief and improved quality of life for women. It highlights the importance of addressing this condition and exploring effective treatment options to empower women to live more fulfilling lives.

Date :
  1. Date Completed 2009-11-24
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

19601704

DOI: Digital Object Identifier

10.1185/03007990903103279

Related Literature

Article Analysis
・Effects of tolterodine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.